The impact of basic atrial rhythm during catheter ablation of atrial fibrillation on clinical outcomes: Lessons from the German Ablation Registry.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
07 2021
Historique:
revised: 05 04 2021
received: 16 12 2020
accepted: 22 04 2021
pubmed: 7 5 2021
medline: 11 8 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

The impact of basic atrial rhythm (sinus rhythm [SR] vs. atrial fibrillation [AF]) during AF ablation on efficacy and safety is unknown. About 3375 patients from the German Ablation Registry undergoing first-time AF ablation were divided according to the type of AF and the basic atrial rhythm during the ablation procedure: paroxysmal AF (PAF) and SR [group Ia], PAF and AF [group Ib]), persistent AF and SR (IIa), and persistent AF and AF (IIb). Patients in SR (n = 2312 [67%]) underwent cryoballoon ablation more often (Ia vs. Ib p = .002 and IIa vs. IIb p = .010, whereas in patients in AF (n = 1063 [33%]) radiofrequency (RF)-based ablation (Ia vs. Ib p = .006 and IIa vs. IIb p = .014) including left and/or right atrial substrate modification was more frequently performed. Depending on the basic rhythm there was no difference regarding arrhythmia recurrence during long-term follow-up. For patients suffering from persistent AF acute procedure-related complications were more often documented when ablated in AF (9.1% vs. 4.6%, p = .012). which was mainly driven by the higher occurrence of pericardial effusion/tamponade. For patients suffering from persistent AF, favorable results were found regarding 366-day Kaplan-Meier estimates of the incidence of MACCE (death, myocardial infarction, and stroke; p = .011) and the composite endpoint of death, myocardial infarction, stroke, and major bleeding (p = .006), when ablated in SR. Basic atrial rhythm at the time of AF ablation did not affect long-term rhythm outcome. For patients suffering from persistent AF a more favorable acute and long-term safety profile was observed when ablated in SR.

Sections du résumé

BACKGROUND
The impact of basic atrial rhythm (sinus rhythm [SR] vs. atrial fibrillation [AF]) during AF ablation on efficacy and safety is unknown.
METHODS
About 3375 patients from the German Ablation Registry undergoing first-time AF ablation were divided according to the type of AF and the basic atrial rhythm during the ablation procedure: paroxysmal AF (PAF) and SR [group Ia], PAF and AF [group Ib]), persistent AF and SR (IIa), and persistent AF and AF (IIb).
RESULTS
Patients in SR (n = 2312 [67%]) underwent cryoballoon ablation more often (Ia vs. Ib p = .002 and IIa vs. IIb p = .010, whereas in patients in AF (n = 1063 [33%]) radiofrequency (RF)-based ablation (Ia vs. Ib p = .006 and IIa vs. IIb p = .014) including left and/or right atrial substrate modification was more frequently performed. Depending on the basic rhythm there was no difference regarding arrhythmia recurrence during long-term follow-up. For patients suffering from persistent AF acute procedure-related complications were more often documented when ablated in AF (9.1% vs. 4.6%, p = .012). which was mainly driven by the higher occurrence of pericardial effusion/tamponade. For patients suffering from persistent AF, favorable results were found regarding 366-day Kaplan-Meier estimates of the incidence of MACCE (death, myocardial infarction, and stroke; p = .011) and the composite endpoint of death, myocardial infarction, stroke, and major bleeding (p = .006), when ablated in SR.
CONCLUSION
Basic atrial rhythm at the time of AF ablation did not affect long-term rhythm outcome. For patients suffering from persistent AF a more favorable acute and long-term safety profile was observed when ablated in SR.

Identifiants

pubmed: 33955108
doi: 10.1111/jce.15072
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1833-1841

Informations de copyright

© 2021 The Authors. Journal of Cardiovascular Electrophysiology Published by Wiley Periodicals LLC.

Références

Hindricks G , Potpara T , Dagres N , et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42:373-498.
Wilke T , Groth A , Mueller S , et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486-493.
Vogler J , Willems S , Sultan A , et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015;66(24):2743-2752.
Fink T , Schlüter M , Heeger CH , et al. Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: the randomized Alster-lost-AF trial (ablation at St. Georg Hospital for long-standing persistent atrial fibrillation). Circ Arrhythm Electrophysiol. 2017;10(7).
Rottner L , Waddell D , Lin T , Metzner A , Rillig A . Innovative tools for atrial fibrillation ablation. Expert Rev Med Devices. 2020;17:555-563.
Rottner L , Bellmann B , Lin T , et al. Catheter ablation of atrial fibrillation: state of the art and future perspectives. Cardiol Ther. 2020;9(1):45-58.
Sarkozy A , Shah D , Saenen J , et al. Contact force in atrial fibrillation: role of atrial rhythm and ventricular contractions: co-force atrial fibrillation study. Circ Arrhythm Electrophysiol. 2015;8(6):1342-1350.
Rivard L , Hocini M , Rostock T , et al. Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm. 2012;9(7):1025-1030.
Reissmann B , Heeger CH , Opitz K , et al. Clinical outcomes of cryoballoon ablation for pulmonary vein isolation: impact of intraprocedural heart rhythm [published online ahead of print November 03, 2020]. Cardiol J. 2020.
Kany S , Brachmann J , Lewalter T , et al. Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry [published online ahead of print October 28, 2020]. Clin Res Cardiol. 2020.
Chun KRJ , Perrotta L , Bordignon S , et al. Complications in catheter ablation of atrial fibrillation in 3,000 consecutive procedures: balloon versus radiofrequency current ablation. JACC Clin Electrophysiol. 2017;3(2):154-161.
Hosseini SM , Rozen G , Saleh A , et al. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol. 2017;3(11):1240-1248.
Fink T , Sciacca V , Feickert S , et al. Outcome of cardiac tamponades in interventional electrophysiology. Europace. 2020;22(8):1240-1251.
Matsuda H , Parwani AS , Attanasio P , et al. Atrial rhythm influences catheter tissue contact during radiofrequency catheter ablation of atrial fibrillation: comparison of contact force between sinus rhythm and atrial fibrillation. Heart Vessels. 2016;31(9):1544-1552.
Lemes C , Kuck KH , Mathew S [Catheter ablation of persistent atrial fibrillation: Where do we go?]. Herz. 2017;42(4):357-363.
Tilz RR , Rillig A , Thum AM , et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol. 2012;60(19):1921-1929.
Steinberg BA , Hellkamp AS , Lokhnygina Y , et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J. 2015;36(5):288-296.
Benjamin EJ , Wolf PA , D'Agostino RB , Silbershatz H , Kannel WB , Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946-952.
Ganesan AN , Chew DP , Hartshorne T , et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591-1602.
Grimm RA , Stewart WJ , Maloney JD , et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993;22(5):1359-1366.
Grimm RA , Stewart WJ , Arheart K , Thomas JD , Klein AL . Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol. 1997;29(3):582-589.

Auteurs

Laura Rottner (L)

Department of Cardiology, Universitäres Herz-und Gefäßzentrum Hamburg-Eppendorf, Hamburg, Germany.

Johannes Brachmann (J)

Department of Cardiology, Klinikum Coburg, Coburg, Germany.

Thorsten Lewalter (T)

Department of Cardiology and Intensive Care, Klinikum München-Thalkirchen, Munich, Germany.

Karl-Heinz Kuck (KH)

LANS Cardio, Hamburg, Germany.

Stephan Willems (S)

Asklepios Klinik St. Georg, Hamburg, Germany.

Lars Eckardt (L)

Department of Cardiology II: Electrophysiologie, Universitätsklinikum Muenster, Münster, Germany.

Matthias Hochadel (M)

Academic Research Organisation for Cardiovascular Medicine, Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany.

Dietrich Andresen (D)

Department of Cardiology, Evangelisches Krankenhaus Hubertus Berlin, Berlin, Germany.

Jochen Senges (J)

Academic Research Organisation for Cardiovascular Medicine, Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany.

Andreas Rillig (A)

Department of Cardiology, Universitäres Herz-und Gefäßzentrum Hamburg-Eppendorf, Hamburg, Germany.

Andreas Metzner (A)

Department of Cardiology, Universitäres Herz-und Gefäßzentrum Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH